Invention Grant
- Patent Title: Crystalline forms of rosuvastatin calcium salt
- Patent Title (中): 瑞舒伐他汀钙盐的结晶形式
-
Application No.: US11883008Application Date: 2006-01-23
-
Publication No.: US07932387B2Publication Date: 2011-04-26
- Inventor: Fritz Blatter , Paul Adriaan Van Der Schaaf , Martin Szelagiewicz
- Applicant: Fritz Blatter , Paul Adriaan Van Der Schaaf , Martin Szelagiewicz
- Applicant Address: DE Ludwigshafen
- Assignee: BASF SE
- Current Assignee: BASF SE
- Current Assignee Address: DE Ludwigshafen
- Agent Shiela A. Loggins
- Priority: EP05100598 20050131
- International Application: PCT/EP2006/050351 WO 20060123
- International Announcement: WO2006/079611 WO 20060803
- Main IPC: C07D239/42
- IPC: C07D239/42 ; A61K31/505 ; A61P3/06
Abstract:
Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] (also known as rosuvastatin) calcium salt and hydrates can exist in new crystal forms B and C. These crystal forms provide a higher diversity on crystalline materials to optimize manufacture, formulation and biological efficiency.
Public/Granted literature
- US20080194604A1 Crystalline Forms Of Rosuvastatin Calcium Salt Public/Granted day:2008-08-14
Information query
